Health Catalyst Inc (HCAT) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

HCAT ranks #3996 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

HCAT is a top-conviction position for CDC Financial, Inc. — at 5.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in HCAT belongs to First Light Asset Management, LLC, but the position matters far more to CDC Financial, Inc., who has 5.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

HCAT reported a net loss of $264.8M over the trailing twelve months.

• Not yet profitable — net loss of $264.8M over the trailing twelve months
• Revenue declined 7.5% year over year
• Net income declined year over year, from -$100.1M to -$264.8M
• Generated $731.0K in positive operating cash flow
• Current ratio of 1.89x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.05x equity — within a conventional range